BioNTech SE (LON:0A3M)
United Kingdom · Delayed Price · Currency is GBP · Price in USD 87.00
-1.16 (-1.32%)
At close: Nov 10, 2026
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of 16.16 billion as of November 10, 2026. Its market cap has decreased by 14.21% in one year.
Market Cap
16.16B
Enterprise Value
4.87B
Revenue
2.07B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.43B to 16.16B, an increase of 564.58%. That is a compound annual growth rate of 30.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 16.23B | -4.58% |
| Dec 31, 2025 | 17.01B | -22.06% |
| Dec 31, 2024 | 21.82B | 10.79% |
| Dec 29, 2023 | 19.70B | -34.99% |
| Dec 30, 2022 | 30.30B | -34.11% |
| Dec 31, 2021 | 45.98B | 219.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 2.01B |
| Genus | 1.54B |
| Oxford Biomedica | 663.17M |
| PureTech Health | 292.74M |
| Avacta Group | 261.89M |
| Bioventix | 101.88M |
| Scancell Holdings | 101.83M |
| 4basebio | 81.73M |